Lonza Group AG/Fr. LONN
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Lonza Group AG
Lonza Group AG is a Swiss multinational chemicals and biotechnology company headquartered in Basel, Switzerland. The company operates primarily in the life sciences sector, offering products and services for pharmaceutical and biotechnology companies, including custom development and manufacturing of active pharmaceutical ingredients, cell and gene therapies, and bioscience solutions. Founded in 1897, Lonza has a significant global presence with numerous production and research facilities worldwide. The company's strategic positioning lies in its comprehensive offering that supports pharmaceutical companies from early-stage development through commercialization, leveraging advanced technologies and extensive expertise in biologics.
Ticker
Fr. LONN
Sector
Primary listing
XSWX
Employees
20,141
Headquarters
Basel, Switzerland
Website
Lonza Group AG Metrics
BasicAdvanced
CHF 38bn
-
-CHF 1.57
0.85
CHF 5.00
0.46%
Price and volume
Market cap
CHF 38bn
Beta
0.85
52-week high
CHF 591.00
52-week low
CHF 454.60
Average daily volume
167k
Dividend rate
CHF 5.00
Financial strength
Current ratio
1.663
Quick ratio
0.588
Long term debt to equity
41.622
Total debt to equity
51.116
Interest coverage (TTM)
10.22%
Profitability
EBITDA (TTM)
2,390
Gross margin (TTM)
37.14%
Net profit margin (TTM)
-1.60%
Operating margin (TTM)
23.49%
Effective tax rate (TTM)
17.80%
Revenue per employee (TTM)
CHF 340,000
Management effectiveness
Return on assets (TTM)
5.44%
Return on equity (TTM)
12.90%
Valuation
Price to revenue (TTM)
5.508
Price to book
4.66
Price to tangible book (TTM)
6.48
Price to free cash flow (TTM)
252.303
Free cash flow yield (TTM)
0.40%
Free cash flow per share (TTM)
2.147
Dividend yield (TTM)
0.92%
Forward dividend yield
0.46%
Growth
Revenue change (TTM)
25.91%
Earnings per share change (TTM)
-115.18%
3-year revenue growth (CAGR)
2.83%
10-year revenue growth (CAGR)
5.78%
3-year earnings per share growth (CAGR)
-53.12%
10-year earnings per share growth (CAGR)
-13.64%
3-year dividend per share growth (CAGR)
12.62%
10-year dividend per share growth (CAGR)
7.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.